All about health

Today HealthMark Group announced its recognition as a Top Workplace in 2025 by USA Today, highlighting its vision to create an inclusive and growth-oriented work environment for HealthMark's dynamic team of employees who support the company's mission...

Submitted research has nearly doubled to a record-breaking 460 abstracts for the 9th Asian and Oceanian Parkinson's Disease and Movement Disorders Congress (AOPMC). "The depth of novel insights that will be unveiled during the AOPMC showcases the...

In Canada, one in 12 people live with a rare disease, and for most people affected, the cost of treatment is unaffordable. Canadians deserve a health care system that provides timely access to quality health services and medications, including...

Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) has approved TREMFYA® (guselkumab), the first and only IL-23 inhibitor offering both subcutaneous (SC) and intravenous (IV) induction options, for the treatment of...

No one should have to choose between paying for prescription drugs and putting food on the table. That's why the Government of Canada is taking action so Canadians can get the medication they need, regardless of their ability to pay. Today, Member...

Nektar Therapeutics today announced that the company will be webcasting its participation in the H.C. Wainwright 3rd Annual Autoimmune & Inflammatory Disease Virtual Conference:...

Armata Pharmaceuticals, Inc. ("Armata" or the "Company"), a clinical-stage biotechnology company focused on the development of high-purity, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat...

Alnylam Pharmaceuticals, Inc. , the leading RNAi therapeutics company, today announced the U.S. Food and Drug Administration (FDA) approval of the supplemental New Drug Application (sNDA) for its RNAi therapeutic, AMVUTTRA® (vutrisiran), for the...

The company's objective was to assess the essential documentation for submission, determine the necessity of conducting clinical trials tailored to the Indian market, and outline the post-market surveillance procedures to ensure compliance with local...

Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") , a clinical-stage biotechnology company leveraging its proprietary DiffuSpheretm technology designed to optimize drug delivery for applications with significant unmet need, today announced...

DelveInsight's "DARZALEX Market Size, Forecast, and Market Insight Report" highlights the details around DARZALEX, a human IgG1k monoclonal antibody that binds with high affinity to the CD38 molecule, which is highly expressed on the surface of...

The official launch and deployment of the CommunAutés Rurales et Éloignées en Santé (CARES) network took place today at Institut national de la recherche scientifique (INRS). Headed by Professor Cathy Vaillancourt of INRS, and co-directed by Benoît...

K-Bro Linen Inc. ("K-Bro" or the "Corporation") today announces its 2024 financial and operating results.  2024 Financial and Operating Highlights RevenueRevenue increased by 16.4% in 2024 to $373.6 million compared to $320.9 million in...

The PenFed Foundation, a national nonprofit organization that supports Veterans in their transition from service to success, today announced it awarded a grant to Home Base, a national non-profit dedicated to healing the invisible wounds of war...

Regulatory News: POXEL SA (Euronext : POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including metabolic dysfunction-associated...

The Collaborative Community Housing Initiative is excited to announce its recent acquisition of a former memory care community in Highland Park, Illinois. This purchase marks a significant step forward in CCHI's mission to create an inclusive living...

A new medical review published in the Journal of Occupational Medicine and Toxicology has uncovered a troubling rise in accelerated silicosis and other serious lung diseases among artificial stone workers. The analysis, led by Dr. Jane C. Fazio and...

Alto Neuroscience, Inc. ("Alto") a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today reported financial results for the full-year ended December 31, 2024, and...

Danaher Corporation announced that it will webcast its quarterly earnings conference call for the first quarter 2025 on Tuesday, April 22, 2025 beginning at 8:00 a.m. ET and lasting approximately one hour. During the call, the company will discuss...

Neogen® Corporation will issue its third-quarter earnings release before the opening of the market on Wednesday, April 9, 2025. Executives from the company will host a webcast and conference call later that morning, beginning at 8:00 a.m. Eastern...

GeneDx , a leader in delivering improved health outcomes through genomic insights, today announced that, effective as of March 15, 2025, the compensation committee of GeneDx's board of directors granted 46,340 restricted stock units ("RSUs") to ten...

Allurion Technologies, Inc. ("Allurion" or the "Company") , a company dedicated to ending obesity, today announced initial results on the combination of the Allurion Program with low-dose GLP-1 therapy to optimize muscle mass and GLP-1 adherence. 52...

Arcellx, Inc. , a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases, today announced the appointments of Andrew Galligan and Kristin Myers to its...

Verastem Oncology , a biopharmaceutical company committed to advancing new medicines for patients with cancer, today reported financial results for the three months and full year ended December 31, 2024, and highlighted recent progress. "In 2024, we...

Hanmi Pharmaceutical Co., Ltd. (the "Company") announced today that, on March 19, 2025, the Company acquired 409,063 common shares (the "Acquired Shares") in the capital of Aptose Biosciences Inc. ("Aptose") from treasury as a result of the...

Angelalign Technology Inc. ("Angelalign Technology" or the "Company") (6699.HK) released its financial results for fiscal year 2024. Driven by rapid expansion in global markets and continued innovation in digital orthodontics, the Company delivered a...

PCCA, a leading FDA-registered supplier of active pharmaceutical ingredients, excipients and consulting for the compounding industry, today announced Gus Bassani, PharmD, will become chief executive officer of its U.S. business unit on April 1,...

While the March 2025 issue of the Journal of Emergency Nursing features the usual impactful articles, it also honors a luminary in emergency nursing, Anne Manton, who passed in December....

The International Society for CNS Drug Development (ISCDD), a non-profit organization dedicated to advancing central nervous system drug development, is pleased to announce that Sharon Mates, PhD, and Steven Paul, MD, have been named the recipients...

Steer Health, a leader in AI-driven healthcare solutions, today announced the launch of SteerConnect, a high impact platform designed to empower how patients find and connect with the right care at the right time. Combining advanced AI triage,...